Skip to main content
Clinical Trials/CTRI/2025/11/096862
CTRI/2025/11/096862
Not yet recruiting
Not Applicable

A study to assess the quality of life (QOL) among women with cervical cancer receiving brachytherapy as a part of definitive radiation treatment in a selected cancer care centre, North east India.

Dr. B Borooah Cancer Institute1 site in 1 country40 target enrollmentStarted: November 15, 2025Last updated:

Overview

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Dr. B Borooah Cancer Institute
Enrollment
40
Locations
1
Primary Endpoint
To determine the quality of life among women with cervical cancer receiving brachytherapy as a part of definitive radiation treatment.

Overview

Brief Summary

This is prospective observational cross-sectional trial to assess the quality of life in patients of carcinoma cervix receiving brachytherapy as part of their curative treatment.

The findings of this research will provide valuable insights for healthcare providers to improve patient centered care, optimize treatment outcomes, and enhance supportive care strategies for cervical cancer patients undergoing brachytherapy.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18.00 Year(s) to 80.00 Year(s) (—)
Sex
Female

Inclusion Criteria

  • Patient diagnosed with cervical cancer and undergoing brachytherapy as a part definitive radiation therapy Patients on follow-up who had completed brachytherapy within the last 3 months.
  • Adults aged 18 years and above, regardless of menopausal status.
  • Patients who are willing to participate in the study.
  • Patients who can understand English, Hindi or Assamese.

Exclusion Criteria

  • Patients with severe co-morbidities such as advanced cardiovascular disease, uncontrolled diabetes, or chronic kidney/liver failure that could independently affect quality of life (QoL) and functionality.

Outcomes

Primary Outcomes

To determine the quality of life among women with cervical cancer receiving brachytherapy as a part of definitive radiation treatment.

Time Frame: At 4 weeks of conclusion of brachytherapy

Secondary Outcomes

  • To find the correlation between the quality of life & the selected demographic variables(At 8 weeks of conclusion of the sample collections)

Investigators

Sponsor
Dr. B Borooah Cancer Institute
Sponsor Class
Research institution and hospital
Responsible Party
Principal Investigator
Principal Investigator

Dr Yanpothung Yanthan

Dr. Bhubaneswar Borooah cancer Institute

Study Sites (1)

Loading locations...

Similar Trials